<sup>89</sup>Zr-Bevacizumab PET Visualizes Heterogeneous Tracer Accumulation in Tumor Lesions of Renal Cell Carcinoma Patients and Differential Effects of Antiangiogenic Treatment
Sjoukje F. Oosting(University Medical Center Groningen), Elisabeth G.E. de Vries(Karolinska University Hospital), Wouter B. Nagengast(University Medical Center Groningen), Rudi Dierckx(University Medical Center Groningen), Thijs H. Oude Munnink(University Medical Center Groningen), Wim J. Sluiter(University Medical Center Groningen), Jourik A. Gietema(University Medical Center Groningen), Sanne de Haas(Roche (Switzerland)), Suzanne C. van Es(University Medical Center Groningen), Adrienne H. Brouwers(University Medical Center Groningen), Stefan Scherer(University of Southern California), Johan R. de Jong(University Medical Center Groningen), Alfons H.H. Bongaerts(University of Groningen), Harry Hollema(University Medical Center Groningen), Marjolijn N. Lub–de Hooge(University Medical Center Groningen), Igle J. de Jong(University of Groningen)
Cited by 114
Related Papers
Response assessment criteria for brain metastases: proposal from the RANO group
|The Lancet Oncology|2015|1.1k
Evidence Based Selection of Housekeeping Genes
|PLoS ONE|2007|772
Brain-Derived Neurotrophic Factor in Brain Disorders: Focus on Neuroinflammation
|Molecular Neurobiology|2018|750
Trastuzumab duocarmazine in locally advanced and metastatic solid tumours and HER2-expressing breast cancer: a phase 1 dose-escalation and dose-expansion study
|The Lancet Oncology|2019|564
Neuroinflammation in Schizophrenia-Related Psychosis: A PET Study
|Journal of Nuclear Medicine|2009|562